{"id":"sct800","_chembl":{"chemblId":"CHEMBL4594605","moleculeType":"Unknown"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=SCT800","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:45:52.677862+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:45:59.334210+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=SCT800","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:46:00.139439+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Coagulation factor VIII exogenous protein","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:46:00.792986+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4594605/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:46:00.685158+00:00"}},"_dailymed":null,"_scrapedAt":"2026-03-28T00:07:00.154Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:46:02.558918+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT07437404","phase":"PHASE3","title":"Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.","status":"RECRUITING","sponsor":"Sinocelltech Ltd.","startDate":"2024-04-26","conditions":"Haemophilia A","enrollment":36},{"nctId":"NCT05888870","phase":"PHASE4","title":"ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2023-11-22","conditions":"Hemophilia A With Inhibitor","enrollment":50},{"nctId":"NCT03947567","phase":"PHASE4","title":"Safety and Efficacy of Long-term Treatment With SCT800 in Previously Treated Hemophilia A Patients.","status":"UNKNOWN","sponsor":"Sinocelltech Ltd.","startDate":"2019-07-26","conditions":"Hemophilia A","enrollment":240},{"nctId":"NCT03815318","phase":"PHASE3","title":"Evaluation of SCT800 in Prophylaxis Therapy on Previous Treated Patients With Severe Hemophilia A","status":"COMPLETED","sponsor":"Sinocelltech Ltd.","startDate":"2019-01-21","conditions":"Hemophilia A","enrollment":73},{"nctId":"NCT03947320","phase":"PHASE3","title":"Safety,Efficacy and Pharmacokinetics Evaluation of SCT800 in Previously Treated Paediatric Patients With Severe Haemophilia A.","status":"UNKNOWN","sponsor":"Sinocelltech Ltd.","startDate":"2019-12-20","conditions":"Hemophilia A","enrollment":70},{"nctId":"NCT02921945","phase":"PHASE3","title":"Efficacy and Safety Study of SCT800 for On-demand Treatment With in Patients With Hemophilia A","status":"UNKNOWN","sponsor":"Sinocelltech Ltd.","startDate":"2016-10","conditions":"Hemophilia A","enrollment":50},{"nctId":"NCT02888223","phase":"PHASE1","title":"Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A","status":"UNKNOWN","sponsor":"Sinocelltech Ltd.","startDate":"2016-09","conditions":"Hemophilia A","enrollment":16}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL4594605"},"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Immune tolerance induction only","Recombinant human coagulation factor VIII"],"phase":"marketed","status":"active","brandName":"SCT800","genericName":"SCT800","companyName":"Institute of Hematology & Blood Diseases Hospital, China","companyId":"institute-of-hematology-blood-diseases-hospital-china","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:46:02.558918+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}